Skip to content

Alprazolam + Sertindole

Overview

Medical Information

Dosage Information

Side Effects

Safety Information

Reference Information

Frequently Asked Questions

Standard Dosage

Adults: * Initial dose: 4 mg once daily. * Titrate slowly every 4-5 days in increments of 4 mg. * Maintenance: 12-20 mg once daily. * Max: 24 mg/day.

Initial dose: 4 mg once daily. * Titrate slowly every 4-5 days in increments of 4 mg. * Maintenance: 12-20 mg once daily. * Max: 24 mg/day.

Children: Not recommended for use in children.

Special Cases: * Elderly Patients: Slower titration and lower maintenance doses. * Patients with Renal Impairment: Careful monitoring and possible dose adjustments. * Patients with Hepatic Impairment: Mild/moderate: slower titration, lower dose. Severe: contraindicated.

**Elderly Patients:** Slower titration and lower maintenance doses. * **Patients with Renal Impairment:** Careful monitoring and possible dose adjustments. * **Patients with Hepatic Impairment:** Mild/moderate: slower titration, lower dose. Severe: contraindicated.

Clinical Use Cases: Not indicated for intubation, surgical procedures, mechanical ventilation, ICU use, or emergency situations.

Dosage Adjustments: Titration based on clinical response and tolerability. ## Side Effects

## **Side Effects

Common Side Effects: Dizziness, dry mouth, nasal congestion, weight gain, orthostatic hypotension, constipation, insomnia, and rhinitis.

Rare but Serious Side Effects: QT prolongation, ventricular arrhythmias, including Torsades de Pointes, neuroleptic malignant syndrome, and seizures.

Long-Term Effects: Tardive dyskinesia, weight gain, and metabolic changes.

Adverse Drug Reactions (ADR): QT interval prolongation is a significant concern. ## Contraindications * History of cardiac arrhythmias, QT prolongation, or congenital long QT syndrome. * Uncorrected hypokalemia or hypomagnesemia. * Concomitant use with strong CYP3A4 inhibitors or drugs that prolong the QT interval. * Severe hepatic impairment. ## Drug Interactions * Drugs that prolong the QT interval (e.g., certain antiarrhythmics, antibiotics). * CYP3A4 inhibitors and inducers. * Drugs that can cause electrolyte imbalances (e.g., diuretics). ## Pregnancy and Breastfeeding * The use of sertindole during pregnancy and breastfeeding is not recommended unless clearly needed, and the potential benefits outweigh the risks. ## Drug Profile Summary (See sections above) ## Popular Combinations: Not commonly used in combination regimens. Monotherapy is preferred whenever possible. ## Precautions * Baseline ECG and periodic monitoring are recommended. * Monitor electrolytes, especially potassium and magnesium. * Caution in patients with risk factors for stroke or seizures. ## FAQs (See relevant information in sections above)

## **Contraindications** * History of cardiac arrhythmias, QT prolongation, or congenital long QT syndrome. * Uncorrected hypokalemia or hypomagnesemia. * Concomitant use with strong CYP3A4 inhibitors or drugs that prolong the QT interval. * Severe hepatic impairment. ## **Drug Interactions** * Drugs that prolong the QT interval (e.g., certain antiarrhythmics, antibiotics). * CYP3A4 inhibitors and inducers. * Drugs that can cause electrolyte imbalances (e.g., diuretics). ## **Pregnancy and Breastfeeding** * The use of sertindole during pregnancy and breastfeeding is not recommended unless clearly needed, and the potential benefits outweigh the risks. ## **Drug Profile Summary** (See sections above) ## **Popular Combinations:** Not commonly used in combination regimens. Monotherapy is preferred whenever possible. ## **Precautions** * Baseline ECG and periodic monitoring are recommended. * Monitor electrolytes, especially potassium and magnesium. * Caution in patients with risk factors for stroke or seizures. ## **FAQs** (See relevant information in sections above)